Kenneth N Raymond

USPTO Granted Patents = 28 (Patent Applications = 1)

CIPO Patents = 4 (Patent Applications = 1)

EPO Patents = 7 (Patent Applications = 3)

Average Co-Inventor Count = 3.0

ph-index = 14

Forward Citations = 444(Granted Patents)

Company Filing History:

21 out of 15,475

University of California

patents

4 out of 3,975

The United States of America As Represented by the United States

The United States As Represented by the United States Department of

patents

Years Active: 1980-2025

Loading Chart...

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12268678 - Formulations of hydroxypyridonate actinide/lanthanide decorporation agents (2025-04-08),

2. 11684614 - Formulations of hydroxypyridonate actinide/lanthanide decorporation agents (2023-06-27),

3. 10352938 - Macrocyclic HOPO chelators (2019-07-16),

4. 9556122 - Luminescent 1-hydroxy-2-pyridinone chelates of lanthanides (2017-01-31),

5. 9439984 - Macrocycles (2016-09-13),

6. 9273059 - Macrocyclic HOPO chelators (2016-03-01),

7. 8729258 - Luminescent macrocyclic lanthanide complexes (2014-05-20),

8. 8557601 - Luminescent 1-hydroxy-2-pyridinone chelates of lanthanides (2013-10-15),

9. 8551453 - Aromatic triamide-lanthanide complexes (2013-10-08),

10. 8173800 - Luminescent macrocyclic lanthanide complexes (2012-05-08),

11. 7718781 - Hydroxypyridonate and hydroxypyrimidinone chelating agents (2010-05-18),

12. 7442558 - Phthalamide-lanthanide complexes for use as luminescent markers (2008-10-28),

13. 7404912 - Salicylamide-lanthanide complexes for use as luminescent markers (2008-07-29),

14. 7018850 - Salicylamide-lanthanide complexes for use as luminescent markers (2006-03-28),

15. 6864103 - Phthalamide-lanthanide complexes for use as luminescent markers (2005-03-08),

Title: Kenneth N. Raymond: Innovator in Chelation Chemistry

Introduction: Kenneth N. Raymond, based in Berkeley, CA, is a prominent inventor recognized for his significant contributions to the field of chelation chemistry. With an impressive portfolio of 27 patents, Raymond’s work has paved the way for advancements in pharmaceutical formulations involving actinide and lanthanide decorporation agents.

Latest Patents: Among his latest innovations, Raymond has developed formulations of hydroxypyridonate actinide/lanthanide decorporation agents. These pharmaceuticals include 1,2-HOPO and 3,2-HOPO chelating agents that are instrumental in effective metal ion removal. Additionally, he has introduced a class of macrocyclic HOPO chelators characterized by their high stability and remarkable quantum yields of lanthanide ion luminescence in aqueous media. These compounds not only showcase superior kinetic stability but also demonstrate low nonspecific binding to polypeptides, making them highly applicable in biotechnological fields.

Career Highlights: Kenneth N. Raymond has made significant strides in academic and industrial research. He is affiliated with the University of California, a prestigious institution known for its research output and innovation. Additionally, he has contributed to projects as a representative of The United States of America, underscoring his impact on public sector research.

Collaborations: Collaborating with notable figures in the field, Raymond has worked alongside Jide Xu and Stephane Petoud. Their collective efforts have furthered research in chelation chemistry and enhanced the effectiveness of therapeutic agents designed to target various metal ions.

Conclusion: Kenneth N. Raymond’s contributions to the field of chelation chemistry through his numerous patents highlight his status as a key innovator in this domain. His continued work not only reflects his dedication to scientific advancement but also positions him as a leading figure in developing solutions for environmental and health-related challenges associated with metal ions.

This text is generated by artificial intelligence and may not be accurate.